Gene · 406921
NIH grants1,675
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,675
Download this page as JSON| Grant | Title | MIR132 papers | Newest fiscal year |
|---|---|---|---|
| R01HL149303 | Pathological flow-induced endothelial damage and plaque erosion | 1 | 2022 |
| R01HL149401 | Molecular Mechanisms of Dystrophic Cardiomyopathy | 1 | 2022 |
| R01MH097236 | Typical and Pathological Cellular Development of the Human Amygdala | 1 | 2022 |
| R01MH097742 | Towards understanding cellular mechanisms of positive symptoms of schizophrenia | 1 | 2022 |
| R01NS102720 | Exosomes from miR-primed endothelial progenitor cells for treating ischemic stroke | 1 | 2022 |
| R01NS103740 | Adenosine receptor mediated therapies for SUDEP | 1 | 2022 |
| R01NS110387 | Brain Recovery after Cardiac Arrest with Metabolic Glycoengineered Stem Cells | 1 | 2022 |
| R21AR078439 | A Hydrogel Ionic Circuit-Based Electrical Stimulation System for Restoration of Denervated Muscles After Peripheral Nerve Injuries | 1 | 2022 |
| R21NS122136 | Transcribed Ultra Conserved Regions in Glioblastoma | 1 | 2022 |
| R25GM060507 | LLU-NIH Initiative for Maximizing Student Development | 1 | 2022 |
| R25MH094612 | Fostering Research Mentorship & Training during Psychiatry Residency Supplement | 1 | 2022 |
| R33MH118160 | Characterization and quantification of CNS cell specific extracellular microvesicles in blood | 1 | 2022 |
| R35CA197452 | Identification of non-coding RNAs to therapeutically target undruggable pathways in metastatic lung adenocarcinoma and squamous cell carcinoma | 1 | 2022 |
| R35CA197707 | Molecular basis for dietary chemoprevention | 1 | 2022 |
| R37MH065635 | Gene Expression in Long-Term Memory | 1 | 2022 |
| R37NS096493 | Pyschosocial Stress and the Response to Stroke | 1 | 2022 |
| RF1AG079002 | The role of APP in neurogenesis and AD in Down syndrome | 1 | 2022 |
| SC1GM127256 | Aberrant Splice Variants as Potential Precision Biomarkers for Aggressive Prostate Cancers in African American Patients | 1 | 2022 |
| T32AI007180 | Infectious Disease and Basic Microbiological Mechanisms. | 1 | 2022 |
| T32DK007276 | Methods in Nephrologic Research | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406921/grants?page=23